Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viking Thera
(NQ:
VKTX
)
64.63
+0.28 (+0.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Viking Thera
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024
January 02, 2024
Lower interest rates and the low valuation of many biotech stocks are likely to result in many drug maker stocks being acquired in 2024.
Via
InvestorPlace
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?
December 12, 2023
Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.
Via
The Motley Fool
Why Viking Therapeutics Was Crushing It This Week
December 08, 2023
Nowadays, it's good to be a developer of next-generation weight loss drugs.
Via
The Motley Fool
What's Going On With Viking Therapeutics Shares Tuesday?
November 14, 2023
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b study
Via
Benzinga
1 Under-the-Radar Stock That Could Triple By 2030
November 04, 2023
This small-cap biotech stock is going to compete against some giants.
Via
The Motley Fool
Earnings Scheduled For October 25, 2023
October 25, 2023
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.
Via
Benzinga
2 Magnificient Growth Stocks I'm Buying in August
August 02, 2023
These biotech stocks could markedly outperform the broader market.
Via
The Motley Fool
9 Analysts Have This to Say About Viking Therapeutics
July 27, 2023
Via
Benzinga
Earnings Preview: Viking Therapeutics
July 25, 2023
Via
Benzinga
Why Are Stocks Down Today?
October 18, 2023
Stocks are down again on Wednesday as investors continue to feel the effects of several major catalysts hitting the market.
Via
InvestorPlace
Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts
October 18, 2023
Pfizer layoffs are a hot topic among PFE stock traders on Wednesday as they pour over the details of the job cuts amid a Covid slump.
Via
InvestorPlace
Topics
Workforce
Exposures
COVID-19
Layoff
Why Is Viking Therapeutics (VKTX) Stock Moving Today?
October 18, 2023
Viking Therapeutics stock is on the move Wednesday as investors react to results from the company's latest clinical trial!
Via
InvestorPlace
Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 18, 2023
Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court...
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
October 11, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair.
Via
Benzinga
Consolidation In Viking Therapeutics Provides An Opportunity
October 01, 2023
Viking Therapeutics Inc. (VKTX) is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases.
Via
Talk Markets
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
September 18, 2023
U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy?
August 23, 2023
NASH treatments are projected to be one of the most sought-after indications in the coming years.
Via
The Motley Fool
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
August 23, 2023
NASH is a surprisingly common ailment, and the first treatments are on the way.
Via
The Motley Fool
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
August 16, 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 08, 2023
Via
Benzinga
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today
August 08, 2023
Novo Nordisk's popular weight loss drug also confers a significant cardioprotective effect, according to a new study.
Via
The Motley Fool
3 Small-Cap Stocks That Could Be Big-Time Winners
July 22, 2023
These stocks come with significant risks. But they could generate huge returns over time.
Via
The Motley Fool
The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?
July 13, 2023
An overweight world is hungry for new treatments. For now, two companies own the market.
Via
Investor's Business Daily
3 Top Biotech Stocks Defying the Bear Market
July 13, 2023
Each has the potential to dramatically outperform the market.
Via
The Motley Fool
2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher
July 12, 2023
Are analysts right to be so bullish about these stocks?
Via
The Motley Fool
The 3 Best Momentum Stocks to Buy in July
July 07, 2023
For those who identify the right shares at the right time, the rewards of momentum stocks far outstrip those of their competitors.
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
June 29, 2023
If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.
Via
InvestorPlace
Better Buy: Nano-X Imaging vs. Viking Therapeutics
June 29, 2023
Which healthcare stock is the better option for growth investors?
Via
The Motley Fool
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
June 28, 2023
Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) shares lost more than 25% of their value due to investor pressure it faced after Eli Lilly And Co (NYSE: LLY) announced data from retatrutide that was...
Via
Benzinga
Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
June 28, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.